JOIN WAITLIST →METHODOLOGY
Quantitative MT5 systems built on falsification. The pipeline is the product until a system earns a release.
THE RULE
A system is guilty until the data fails to kill it. Backtests are a filter, not a sales deck. Live prices are the only court that matters. Nothing is offered to the public while it is still a study.
Every system here is directional. Risk is defined before the order. There is no recovery logic. If it needs a trick, it does not have an edge.
THE PIPELINE
- 01 BUILDDefine the hypothesis. If it needs a recovery trick, it is discarded here.
- 02 BACKTESTRun it on historical data with costs. Hold-out windows can kill it.
- 03 FORWARD TESTSame logic on live prices. The book stays public if it breaks.
- 04 TRADE REAL / PROP CAPITALSurvivors run under funded-account drawdown constraints.
- 05 RELEASENothing is offered until the live book has earned it.
WHAT GETS REFUSED
NO MARTINGALE
Size does not increase after a loss. If the next trade needs a larger bet to 'get back', the system does not have an edge.
NO GRID / NO AVERAGING
Losers are not stacked. A hard stop is set before entry. The stop is not widened to stay in the trade.
NO CURVE FIT AS PROOF
A pretty in-sample equity curve is not a promotion. Hold-out and forward books can kill a study.
NO HIDDEN BREAKS
If a system fails in forward testing, the data stays up. Learning what does not work is part of the book.
HOW A SYSTEM GETS PROMOTED
Research can stay public. Promotion cannot be claimed. A study moves to forward testing only after the historical sample, costs, and hold-out window are written down. It moves to funded capital only after the forward book has operated inside a hard drawdown cap.
Release is last. There is no listing, no license, and no allocation story until that last gate is passed. Follow the book before anything is for sale.